Concepedia

Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

Joyce O’Shaughnessy, Joanne L. Blum, Vladimir Moiseyenko, Stephen E. Jones, David Miles, Diana Bell, R. Rosso, L. Mauriac, B Osterwalder, Hans Ulrich Burger,

Annals of Oncology · 2001 · 305 citations · 14 references

DOIFull text

Open access

Concepts

References

14

WHO Handbook for Reporting Results of Cancer Treatment

M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text

, , +11

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations

, , +12

Patient preferences for oral versus intravenous palliative chemotherapy.

Geoffrey Liu, E. Franssen, Margaret I. Fitch et al. · Journal of Clinical Oncology · 1997 · 920 citations

, , +14

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1999 · 791 citations

, , +16

Treatment of Breast Cancer

Gabriel N. Hortobágyi · New England Journal of Medicine · 1998 · 781 citations

, , +8